Next Article in Journal
The Effects of Multidisciplinary Team Meetings on Clinical Practice for Colorectal, Lung, Prostate and Breast Cancer: A Systematic Review
Next Article in Special Issue
Labile Heme and Heme Oxygenase-1 Maintain Tumor-Permissive Niche for Endometriosis-Associated Ovarian Cancer
Previous Article in Journal
Gene Panel Testing for Breast Cancer Reveals Differential Effect of Prior BRCA1/2 Probability
Previous Article in Special Issue
Reply to Auclin et al. Comment on “Hopkins et al. Value of the Lung Immune Prognostic Index in Patients with Non-Small Cell Lung Cancer Initiating First-Line Atezolizumab Combination Therapy: Subgroup Analysis of the IMPOWER150 Trial. Cancers 2021, 13, 1176”
 
 
Article

Article Versions Notes

Cancers 2021, 13(16), 4157; https://doi.org/10.3390/cancers13164157
Action Date Notes Link
article xml file uploaded 18 August 2021 16:37 CEST Original file -
article xml uploaded. 18 August 2021 16:37 CEST Update https://www.mdpi.com/2072-6694/13/16/4157/xml
article pdf uploaded. 18 August 2021 16:37 CEST Version of Record https://www.mdpi.com/2072-6694/13/16/4157/pdf
article supplementary file uploaded. 18 August 2021 16:37 CEST - https://www.mdpi.com/2072-6694/13/16/4157#supplementary
article html file updated 18 August 2021 16:38 CEST Original file -
article html file updated 28 July 2022 06:41 CEST Update https://www.mdpi.com/2072-6694/13/16/4157/html
Back to TopTop